COM:CENTURYTX
Century Therapeutics
- Stock
Last Close
1.24
22/11 21:00
Market Cap
102.89M
Beta: -
Volume Today
511.90K
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|
average inventory | 2.11M - | 815K 61.34% | -125K 115.34% | |||
average payables | 4.82M - | 7.84M 62.80% | 6.53M 16.76% | 4.10M 37.20% | ||
average receivables | 515.50K - | 579K 12.32% | 515K 11.05% | 722.50K 40.29% | ||
book value per share | -2.21 - | -2.55 15.30% | 12.23 580.55% | 5.24 57.15% | 3.11 40.58% | |
capex per share | -0.06 - | -0.24 297.52% | -1.39 490.69% | -0.53 61.83% | -0.23 56.30% | |
capex to depreciation | -9.88 - | -7.01 29.07% | -12.00 71.21% | -3.63 69.78% | -1.05 70.96% | |
capex to operating cash flow | 0.15 - | 0.24 56.47% | 0.51 112.23% | -2.18 531.04% | 0.16 107.12% | |
capex to revenue | -5.89 - | -6.15 4.41% | ||||
cash per share | 1.96 - | 1.81 7.53% | 6.88 279.70% | 5.46 20.61% | 2.91 46.69% | |
days of inventory on hand | ||||||
days payables outstanding | 76.70 - | |||||
days sales outstanding | 54.76 - | 108.60 98.32% | ||||
debt to assets | 0.20 - | 0.06 71.55% | 0.10 76.86% | 0.13 31.50% | ||
debt to equity | -0.20 - | 0.06 131.29% | 0.16 157.51% | 0.26 59.74% | ||
dividend yield | ||||||
earnings yield | -0.26 - | -0.06 77.88% | -0.19 225.67% | -0.44 136.92% | -0.69 57.06% | |
enterprise value | 905.86M - | 948.72M 4.73% | 480.76M 49.33% | 261.44M 45.62% | 197.77M 24.35% | |
enterprise value over ebitda | -48.77 - | -20.16 58.67% | -5.09 74.76% | -2.16 57.63% | -1.76 18.17% | |
ev to operating cash flow | -56.03 - | -22.99 58.97% | -5.40 76.50% | 18.60 444.43% | -2.23 112.00% | |
ev to sales | 50.29 - | 88.49 75.97% | ||||
free cash flow per share | -0.45 - | -1.22 173.00% | -4.14 238.39% | -0.29 93.07% | -1.72 501.84% | |
free cash flow yield | -0.02 - | -0.05 173.00% | -0.26 387.10% | -0.06 78.58% | -0.52 829.95% | |
graham net net | -2.40 - | -3.25 35.24% | 5.61 272.75% | 2.29 59.19% | -0.05 101.99% | |
graham number | 17.14 - | 8.65 49.50% | 28.53 229.73% | 16.35 42.70% | 12.71 22.28% | |
income quality | 0.07 - | 0.77 1,066.17% | 0.93 20.58% | -0.11 111.55% | 0.65 703.81% | |
intangibles to total assets | 0 - | 0.09 Infinity% | 0 100% | 0 | 0 | |
interest coverage | -141.46 - | -74.42 47.39% | -121.11 62.75% | -231.82 91.40% | ||
interest debt per share | 0.52 - | 0.81 55.26% | 0.87 7.36% | 0.82 6.11% | ||
inventory turnover | ||||||
invested capital | -0.20 - | 0.06 131.29% | 0.16 157.51% | 0.26 59.74% | ||
market cap | 949.92M - | 954.38M 0.47% | 513.75M 46.17% | 296.29M 42.33% | 196.92M 33.54% | |
net current asset value | -98.63M - | -134.39M 36.25% | 187.02M 239.16% | 135.91M 27.32% | 1.05M 99.23% | |
net debt to ebitda | 2.37 - | 0.12 94.93% | 0.35 190.45% | 0.29 17.67% | -0.01 102.63% | |
net income per share | -5.91 - | -1.31 77.88% | -2.96 126.24% | -2.27 23.37% | -2.30 1.64% | |
operating cash flow per share | -0.39 - | -0.99 154.06% | -2.75 178.32% | 0.24 108.85% | -1.49 713.73% | |
payables turnover | 4.76 - | |||||
receivables turnover | 6.67 - | 3.36 49.58% | ||||
research and ddevelopement to revenue | 20.61 - | 41.48 101.23% | ||||
return on tangible assets | -2.71 - | -0.56 79.26% | -0.22 60.97% | -0.27 22.83% | -0.38 40.81% | |
revenue per share | 0.09 - | 0.04 58.14% | ||||
roe | 2.68 - | 0.51 80.82% | -0.24 147.08% | -0.43 78.84% | -0.74 71.05% | |
roic | 2.69 - | 0.75 71.98% | -0.22 128.88% | -0.34 57.16% | -0.45 32.66% | |
sales general and administrative to revenue | 6.13 - | 15.53 153.42% | ||||
shareholders equity per share | -2.21 - | -2.55 15.30% | 12.23 580.55% | 5.24 57.15% | 3.11 40.58% | |
stock based compensation to revenue | 2.05 - | 6.54 218.81% | ||||
tangible asset value | -91.86M - | -115.80M 26.07% | 396.24M 442.16% | 302.74M 23.60% | 184.75M 38.97% | |
tangible book value per share | -2.21 - | -2.77 25.48% | 12.23 541.57% | 5.24 57.15% | 3.11 40.58% | |
working capital | 81.13M - | 66.69M 17.80% | 212.50M 218.66% | 289.90M 36.43% | 159.15M 45.10% |
All numbers in (except ratios and percentages)